Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial

Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial

BackgroundAtopic dermatitis (AD) has increased rapidly with rapid urbanization; however, the treatment options for AD are lacking because the commonly used therapies can only alleviate symptoms. Limosilactobacillus reuteri (L. reuteri), FN041 is a specific strain isolated from human breast milk, and...

Full description

Bibliographic Details
Main Authors: Renqiang Yu, Yizhe Ma, Zichen Luo, Ce Qi, Anni Xie, Yifan Jiang, Baoli Zhu, Jin Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Microbiology
Subjects:
atopic dermatitis
Limosilactobacillus reuteri
infant
microbiota
breast milk
probiotics
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1267448/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1267448/full

Similar Items